Management of Endometriosis-Related Pelvic Pain

Evidence Assessment

• Superior hypogastric nerve blocks are considered unproven with insufficient evidence for neurogenic pelvic pain according to Aetna, which specifically lists this procedure as not covered for this indication 1
• Neurolytic blocks of the superior hypogastric plexus should be limited to patients with short life expectancy and are primarily indicated for cancer-related pain, not benign conditions like endometriosis 1

Recommended Treatment Approach

• First-line treatment should be NSAIDs for immediate pain relief, used at appropriate doses and schedules 2
• GnRH agonists for at least three months provide significant pain relief and are appropriate for chronic pelvic pain, even without surgical confirmation of endometriosis 2, 3
• When using GnRH agonists long-term, add-back therapy should be implemented to reduce bone mineral loss without reducing pain relief efficacy 2, 3
• Oral contraceptives and progestins are effective alternatives with similar efficacy to other hormonal treatments 3

Surgical Considerations

• For severe endometriosis, medical treatment alone may not be sufficient 3
• Surgical exploration may be warranted if conservative treatments fail, though up to 44% of women experience symptom recurrence within one year after surgery 3

Important Clinical Considerations

• The patient has already had a hysterectomy and previous endometrial tissue removal, yet continues to have symptoms, suggesting residual endometriosis tissue or central sensitization 2
• Hormone replacement therapy with estrogen is not contraindicated following hysterectomy and bilateral salpingo-oophorectomy for endometriosis, if that becomes a consideration 3

Effective Treatment Options for Endometriosis

Introduction to Treatment

• Surgical excision by a specialist is considered the definitive treatment for endometriosis, while medical therapies effectively temporize symptoms but cannot eradicate the disease. 4

Treatment Considerations

• Continuous oral contraceptive pills are as effective as GnRH agonists for pain control while causing far fewer side effects, with benefits including low cost, minimal side effects, and widespread availability, according to the American College of Radiology. 5
• Hysterectomy with bilateral salpingo-oophorectomy remains the definitive approach for completed childbearing, with benefits including definitive treatment for pain in appropriate candidates, as noted by the American College of Radiology. 5
• Preoperative imaging reduces morbidity and mortality by decreasing incomplete surgeries and need for repeat procedures, as recommended by the American College of Radiology. 4, 5

Laparoscopic Management of Grade 4 Endometriosis

Preoperative Planning

• The American College of Radiology recommends obtaining high-quality preoperative imaging with MRI pelvis to map disease extent, identify deep infiltrating lesions, and plan surgical approach, with transvaginal ultrasound as an acceptable alternative or complementary modality 6

Intraoperative Technique

• The British Journal of Cancer guidelines suggest performing systematic exploration, inspection, and palpation of the entire abdomen and pelvis, and obtaining peritoneal washings for cytology at the start of the procedure 7
• Bowel resection should be performed when necessary to achieve complete disease removal or prevent obstruction, according to the British Journal of Cancer 8
• Bladder endometriosis requires partial cystectomy with complete excision of visible disease, as recommended by the British Journal of Cancer 8

Critical Pitfalls to Avoid

• The American College of Radiology advises against converting to laparotomy unless there is suspected involvement of pelvic or abdominal organs that cannot be safely managed laparoscopically 9

Treatment Options for Endometriosis

First-Line Medical Management

• The American Academy of Family Physicians recommends starting with NSAIDs for immediate pain relief, followed by combined oral contraceptives or progestins as first-line hormonal therapy, reserving GnRH agonists for refractory cases and surgery for severe disease or when medical management fails 10
• Combined oral contraceptives and progestins are equally effective first-line options with superior safety profiles compared to more costly regimens, providing effective pain relief compared to placebo 10, 11
• Progestins demonstrate similar efficacy to oral contraceptives in reducing pain and lesion size, although they do not eradicate endometriosis completely 10, 11

Second-Line Medical Management

• GnRH agonists for at least 3 months provide significant pain relief when first-line therapies fail, with mandatory add-back therapy to prevent bone mineral loss without reducing pain relief efficacy 10, 11
• Danazol for at least 6 months shows equivalent efficacy to GnRH agonists in reducing pain, with Level A evidence supporting its use 10, 11

Surgical Management

• Surgery should be considered when medical treatment is ineffective, contraindicated, or for severe endometriosis, with surgical excision by a specialist being the definitive treatment 10, 11, 12
• Up to 44% of women experience symptom recurrence within one year after surgery, highlighting the importance of ongoing management 10, 11

Important Clinical Pitfalls

• No medical therapy eradicates endometriosis lesions completely, and pain severity correlates poorly with laparoscopic appearance but correlates with lesion depth 10, 11
• Medical treatment does not improve future fertility outcomes, and hormonal suppression should not be used in women actively seeking pregnancy 10, 11
• Hormone replacement therapy with estrogen is not contraindicated following hysterectomy and bilateral salpingo-oophorectomy for endometriosis 10, 11

Treatment of Endometriosis in Women Who Do Not Want More Children

Surgical Management

• Ovarian preservation can be considered in selected cases depending on the patient's age and genetic risk factors, though bilateral oophorectomy provides more complete hormonal suppression, as noted by the Annals of Oncology 13
• If hysterectomy is performed without oophorectomy, ongoing medical suppression may still be required as residual ovarian function can stimulate remaining endometriotic tissue, according to the Annals of Oncology 13

Relative Contraindications and Adverse Effects of Dienogest 2 mg in Women with Endometriosis

Contraindications

• In women of reproductive age receiving dienogest 2 mg for symptomatic endometriosis, progestin therapy is contraindicated in the presence of low‑grade serous epithelial ovarian cancer, granulosa‑cell tumors, certain sarcomas (e.g., leiomyosarcoma, stromal sarcoma), and advanced endometrioid uterine adenocarcinoma. 14

Adverse Effects

• Acne is reported as a common adverse effect of dienogest 2 mg, occurring in fewer than 10 % of treated women. 14